Summit Therapeutics SMMT Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Summit Therapeutics’s 10-Q, filed August 6, 2024, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's operating margin?
- Summit Therapeutics (SMMT) reported operating margin of -268,266.8% in Q2 2023.
- How has Summit Therapeutics's operating margin changed year-over-year?
- Summit Therapeutics's operating margin decreased by 6724.9% year-over-year, from -3,930.7% to -268,266.8%.
- What is the long-term trend for Summit Therapeutics's operating margin?
- Over 2 years (2020 to 2022), Summit Therapeutics's operating margin has grown at a 28.6% compound annual growth rate (CAGR), from -6,185.2% to -10,225.4%.
- What does operating margin mean?
- The profit left from core operations for every dollar of sales, before interest and taxes.
- How do you interpret operating margin?
- Expanding operating margin shows operating leverage — revenue growing faster than the cost base. Compression points to rising overhead, pricing pressure, or investment ahead of revenue.
- How does operating margin compare across companies?
- Strong cross-company signal within a sector. Capital-light businesses sustain higher operating margins than capital-intensive ones.